Treatment of Bacterial Vaginosis in the Elderly
The recommended first-line treatment for bacterial vaginosis (BV) in elderly women is metronidazole 500 mg orally twice daily for 7 days, which has demonstrated a clinical cure rate of approximately 84%. 1
Diagnosis Confirmation
Before initiating treatment, confirm BV diagnosis using at least 3 of the following Amsel's criteria:
- Homogeneous, white, non-inflammatory discharge adhering to vaginal walls
- Presence of clue cells on microscopic examination
- Vaginal fluid pH greater than 4.5
- Fishy odor of vaginal discharge before or after addition of 10% KOH (whiff test)
First-Line Treatment Options
The CDC recommends the following equally effective regimens:
Oral options:
- Metronidazole 500 mg orally twice daily for 7 days
- Clindamycin 300 mg orally twice daily for 7 days
Topical options:
- Metronidazole gel 0.75%, one full applicator (5 g) intravaginally once daily for 5 days
- Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days
Alternative Regimens
- Metronidazole 2 g orally in a single dose
- Tinidazole 2 g once daily for 2 days or 1 g once daily for 5 days 2
- Clindamycin ovules 100 g intravaginally once at bedtime for 3 days
Special Considerations for Elderly Patients
Medication selection:
- Consider potential drug interactions with other medications commonly used by elderly patients
- Assess renal and hepatic function before prescribing metronidazole or tinidazole
- For patients with difficulty using vaginal applicators, oral therapy may be preferred
Important precautions:
- Patients must avoid alcohol during metronidazole or tinidazole treatment and for 24 hours afterward to prevent disulfiram-like reactions 1
- Clindamycin cream and ovules are oil-based and may weaken latex condoms and diaphragms 1
- Monitor for side effects, which may be more pronounced in elderly patients
Management of Recurrent BV
Recurrence is common, with 50-80% of women experiencing recurrence within a year of treatment 1, 3. For recurrent BV:
- Use an extended course of metronidazole (500 mg twice daily for 10-14 days) 3
- If ineffective, consider metronidazole vaginal gel 0.75% for 10 days, followed by twice weekly application for 3-6 months 3
- Consider using a different treatment regimen than the initial one 1
Follow-up
- Routine follow-up is unnecessary if symptoms resolve 1
- Patients should return for additional therapy if symptoms recur 1
Emerging Treatment Options
Recent research has shown that dequalinium chloride (a broad-spectrum antiseptic) demonstrated noninferiority to metronidazole with similar cure rates but better tolerability 4. This may be considered as an alternative option, particularly in patients who cannot tolerate or have contraindications to standard antibiotic therapy.
Common Pitfalls to Avoid
- Treating without confirming diagnosis
- Failing to warn patients about alcohol avoidance with metronidazole/tinidazole
- Not considering potential drug interactions in elderly patients who may be on multiple medications
- Routine treatment of sexual partners is not recommended as clinical trials indicate that partner treatment does not affect a woman's response to therapy 1
- Not addressing recurrent BV appropriately, which affects a significant percentage of patients